# PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)

> **NCT04582916** · PHASE1 · RECRUITING · sponsor: **National Institute of Mental Health (NIMH)** · enrollment: 64 (estimated)

## Conditions studied

- Depression

## Interventions

- **DRUG:** 11C-MCI
- **DRUG:** 11CPS13

## Key facts

- **NCT ID:** NCT04582916
- **Lead sponsor:** National Institute of Mental Health (NIMH)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-07-20
- **Primary completion:** 2029-10-03
- **Final completion:** 2030-04-11
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04582916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04582916, "PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04582916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*